AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MYRIAD GENETICS INC Director's Dealing 2018

Jun 5, 2018

32566_dirs_2018-06-05_d861c614-c946-4126-b55f-f1a20badb291.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-06-01

Reporting Person: LANGER DENNIS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	M	30000	$24.4	Acquired	69743	Direct
2018-06-01	Common Stock	S	30000	$38.9	Disposed	39743	Direct
2018-06-04	Common Stock	M	10000	$24.39	Acquired	49743	Direct
2018-06-04	Common Stock	S	10000	$39.9	Disposed	39743	Direct
2018-06-04	Common Stock	M	8404	$21.29	Acquired	48147	Direct
2018-06-04	Common Stock	S	8404	$39.9	Disposed	39743	Direct
2018-06-05	Common Stock	M	1227	$21.29	Acquired	40970	Direct
2018-06-05	Common Stock	S	1227	$39.9	Disposed	39743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-04	Non-Qualified Stock Option (right to buy)	$21.29	M	8404	Disposed	2021-12-02	Common Stock (8404)	Direct
2018-06-05	Non-Qualified Stock Option (right to buy)	$21.29	M	1227	Disposed	2021-12-02	Common Stock (1227)	Direct
2018-06-04	Non-Qualified Stock Option (right to buy)	$24.39	M	10000	Disposed	2018-11-13	Common Stock (10000)	Direct
2018-06-01	Non-Qualified Stock Option (right to buy)	$24.4	M	30000	Disposed	2019-11-05	Common Stock (30000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.